Chinese Journal of Dermatology ›› 2023, Vol. 56 ›› Issue (6): 567-570.doi: 10.35541/cjd.20220918
• Reviews • Previous Articles
Zhang Liming, Xiao Ting
Received:
2022-12-27
Revised:
2023-03-23
Online:
2023-06-15
Published:
2023-06-05
Contact:
Xiao Ting
E-mail:cmuxt@126.com
Supported by:
Zhang Liming, Xiao Ting. Update of the autoimmune pathogenesis of chronic spontaneous urticaria[J]. Chinese Journal of Dermatology, 2023, 56(6): 567-570.doi:10.35541/cjd.20220918
[1] | Zuberbier T, Abdul Latiff AH, Abuzakouk M, et al. The international EAACI/GA2LEN/EuroGuiDerm/APAAACI guideline for the definition, classification, diagnosis, and management of urticaria[J]. Allergy, 2022,77(3):734⁃766. doi: 10.1111/all. 15090. |
[2] | Leznoff A, Josse RG, Denburg J, et al. Association of chronic urticaria and angioedema with thyroid autoimmunity[J]. Arch Dermatol, 1983,119(8):636⁃640. doi: 10.1001/archderm.119. 8.636. |
[3] | Grattan CE, Francis DM, Hide M, et al. Detection of circulating histamine releasing autoantibodies with functional properties of anti⁃IgE in chronic urticaria[J]. Clin Exp Allergy, 1991,21(6):695⁃704. doi: 10.1111/j.1365⁃2222.1991.tb03198.x. |
[4] | Hide M, Francis DM, Grattan CE, et al. Autoantibodies against the high⁃affinity IgE receptor as a cause of histamine release in chronic urticaria[J]. N Engl J Med, 1993,328(22):1599⁃1604. doi: 10.1056/NEJM199306033282204. |
[5] | Bar⁃Sela S, Reshef T, Mekori YA. IgE antithyroid microsomal antibodies in a patient with chronic urticaria[J]. J Allergy Clin Immunol, 1999,103(6):1216⁃1217. doi: 10.1016/s0091⁃6749(99)70204⁃6. |
[6] | Konstantinou GN, Asero R, Ferrer M, et al. EAACI taskforce position paper: evidence for autoimmune urticaria and proposal for defining diagnostic criteria[J]. Allergy, 2013,68(1):27⁃36. doi: 10.1111/all.12056. |
[7] | Schoepke N, Asero R, Ellrich A, et al. Biomarkers and clinical characteristics of autoimmune chronic spontaneous urticaria: Results of the PURIST Study[J]. Allergy, 2019,74(12):2427⁃2436. doi: 10.1111/all.13949. |
[8] | Kolkhir P, Altrichter S, Asero R, et al. Autoimmune diseases are linked to type IIb autoimmune chronic spontaneous urticaria[J]. Allergy Asthma Immunol Res, 2021,13(4):545⁃559. doi: 10. 4168/aair.2021.13.4.545. |
[9] | Maronese CA, Ferrucci SM, Moltrasio C, et al. IgG and IgE autoantibodies to IgE receptors in chronic spontaneous urticaria and their role in the response to mmalizumab[J]. J Clin Med, 2023,12(1):378. doi: 10.3390/jcm12010378. |
[10] | Panaszek B, Pawłowicz R, Grzegrzółka J, et al. Autoreactive IgE in chronic spontaneous/idiopathic urticaria and basophil/mastocyte priming phenomenon, as a feature of autoimmune nature of the syndrome[J]. Arch Immunol Ther Exp (Warsz), 2017,65(2):137⁃143. doi: 10.1007/s00005⁃016⁃0417⁃7. |
[11] | de Montjoye L, Darrigade AS, Giménez⁃Arnau A, et al. Correlations between disease activity, autoimmunity and biological parameters in patients with chronic spontaneous urticaria[J]. Eur Ann Allergy Clin Immunol, 2021,53(2):55⁃66. doi: 10.23822/EurAnnACI.1764⁃1489.132. |
[12] | Oda Y, Fukunaga A, Washio K, et al. Improved FcεRI⁃mediated CD203c basophil responsiveness reflects rapid responses to omalizumab in chronic spontaneous urticaria[J]. J Allergy Clin Immunol Pract, 2021,9(3):1166⁃1176.e8. doi: 10.1016/j.jaip. 2020.08.048. |
[13] | Huang AH, Chichester KL, Saini SS. Association of basophil parameters with disease severity and duration in chronic spontaneous urticaria (CSU)[J]. J Allergy Clin Immunol Pract, 2020,8(2):793⁃795.e6. doi: 10.1016/j.jaip.2019.08.004. |
[14] | Oda Y, Fukunaga A, Washio K, et al. Low responsiveness of basophils via FcεRI reflects disease activity in chronic spontaneous urticaria[J]. J Allergy Clin Immunol Pract, 2019,7(8):2835⁃2844.e7. doi: 10.1016/j.jaip.2019.05.020. |
[15] | Hashimoto T, Yokozeki H, Karasuyama H, et al. IL⁃31⁃generating network in atopic dermatitis comprising macrophages, basophils, thymic stromal lymphopoietin, and periostin[J]. J Allergy Clin Immunol, 2023,151(3):737⁃746.e6. doi: 10.1016/j.jaci.2022.11.009. |
[16] | Kaplan AP, Giménez⁃Arnau AM, Saini SS. Mechanisms of action that contribute to efficacy of omalizumab in chronic spontaneous urticaria[J]. Allergy, 2017,72(4):519⁃533. doi: 10.1111/all. 13083. |
[17] | Kay AB, Ying S, Ardelean E, et al. Calcitonin gene⁃related peptide and vascular endothelial growth factor are expressed in lesional but not uninvolved skin in chronic spontaneous urticaria[J]. Clin Exp Allergy, 2014,44(8):1053⁃1060. doi: 10.1111/cea. 12348. |
[18] | Yanase Y, Takahagi S, Hide M. Chronic spontaneous urticaria and the extrinsic coagulation system[J]. Allergol Int, 2018,67(2):191⁃194. doi: 10.1016/j.alit.2017.09.003. |
[19] | Rauber MM, Pickert J, Holiangu L, et al. Omalizumab response correlates with reduced IFN⁃γ⁃, IL⁃10⁃ and IL⁃31⁃secreting cells in chronic spontaneous urticaria[J]. J Eur Acad Dermatol Venereol, 2020,34(9):2078⁃2085. doi: 10.1111/jdv.16216. |
[20] | Grieco T, Porzia A, Paolino G, et al. IFN⁃γ/IL⁃6 and related cytokines in chronic spontaneous urticaria: evaluation of their pathogenetic role and changes during omalizumab therapy[J]. Int J Dermatol, 2020,59(5):590⁃594. doi: 10.1111/ijd.14812. |
[21] | de Montjoye L, Choteau M, Herman A, et al. IL⁃6 and IL⁃1β expression is increased in autologous serum skin test of patients with chronic spontaneous urticaria[J]. Allergy, 2019,74(12):2522⁃2524. doi: 10.1111/all.13928. |
[22] | Toubi E, Vadasz Z. The emerging role of IL⁃17 in the immune⁃pathogenesis of chronic spontaneous urticaria[J]. Immunotargets Ther, 2020,9:217⁃223. doi: 10.2147/ITT.S266410. |
[23] | Sabag DA, Matanes L, Bejar J, et al. Interleukin⁃17 is a potential player and treatment target in severe chronic spontaneous urticaria[J]. Clin Exp Allergy, 2020,50(7):799⁃804. doi: 10. 1111/cea.13616. |
[24] | Auyeung P, Mittag D, Hodgkin PD, et al. Autoreactive T cells in chronic spontaneous urticaria target the IgE Fc receptor Iα subunit[J]. J Allergy Clin Immunol, 2016,138(3):761⁃768.e4. doi: 10.1016/j.jaci.2016.04.036. |
[25] | Bracken SJ, Abraham S, MacLeod AS. Autoimmune theories of chronic spontaneous urticaria[J]. Front Immunol, 2019,10:627. doi: 10.3389/fimmu.2019.00627. |
[26] | Kolkhir P, Church MK, Weller K, et al. Autoimmune chronic spontaneous urticaria: what we know and what we do not know[J]. J Allergy Clin Immunol, 2017,139(6):1772⁃1781.e1. doi: 10.1016/j.jaci.2016.08.050. |
[27] | Altrichter S, Peter HJ, Pisarevskaja D, et al. IgE mediated autoallergy against thyroid peroxidase⁃a novel pathomechanism of chronic spontaneous urticaria?[J/OL]. PLoS One, 2011,6(4):e14794. doi: 10.1371/journal.pone.0014794. |
[28] | Atta AM, Rodrigues MZ, Sousa CP, et al. Autoantibody production in chronic idiopathic urticaria is not associated with helicobacter pylori infection[J]. Braz J Med Biol Res, 2004,37(1):13⁃17. doi: 10.1590/s0100⁃879x2004000100002. |
[29] | Concha LB, Chang CC, Szema AM, et al. IgE antithyroid antibodies in patients with Hashimoto′s disease and chronic urticaria[J]. Allergy Asthma Proc, 2004,25(5):293⁃296. |
[30] | Zhang L, Qiu L, Wu J, et al. IgE and IgG anti⁃thyroid autoantibodies in Chinese patients with chronic spontaneous urticaria and a literature review[J]. Allergy Asthma Immunol Res, 2022,14(1):131⁃142. doi: 10.4168/aair.2022.14.1.131. |
[31] | Sánchez J, Sánchez A, Cardona R. Causal relationship between anti⁃TPO IgE and chronic urticaria by in vitro and in vivo tests[J]. Allergy Asthma Immunol Res, 2019,11(1):29⁃42. doi: 10. 4168/aair.2019.11.1.29. |
[32] | Sánchez J, Sánchez A, Cardona R. Clinical characterization of patients with chronic spontaneous urticaria according to anti⁃TPO IgE levels[J]. J Immunol Res, 2019,2019:4202145. doi: 10.1155/2019/4202145. |
[33] | Schmetzer O, Lakin E, Topal FA, et al. IL⁃24 is a common and specific autoantigen of IgE in patients with chronic spontaneous urticaria[J]. J Allergy Clin Immunol, 2018,142(3):876⁃882. doi: 10.1016/j.jaci.2017.10.035. |
[34] | Altrichter S, Zampeli V, Ellrich A, et al. IgM and IgA in addition to IgG autoantibodies against FcɛRIα are frequent and associated with disease markers of chronic spontaneous urticaria[J]. Allergy, 2020,75(12):3208⁃3215. doi: 10.1111/all.14412. |
[35] | Kolkhir P, Kovalkova E, Chernov A, et al. Autoimmune chronic spontaneous urticaria detection with IgG anti⁃TPO and total IgE[J]. J Allergy Clin Immunol Pract, 2021,9(11):4138⁃4146.e8. doi: 10.1016/j.jaip.2021.07.043. |
[36] | Johal KJ, Chichester KL, Oliver ET, et al. The efficacy of omalizumab treatment in chronic spontaneous urticaria is associated with basophil phenotypes[J]. J Allergy Clin Immunol, 2021,147(6):2271⁃2280.e8. doi: 10.1016/j.jaci.2021.02.038. |
[37] | O′Donnell BF, O′Neill CM, Francis DM, et al. Human leucocyte antigen classⅡ associations in chronic idiopathic urticaria[J]. Br J Dermatol, 1999,140(5):853⁃858. doi: 10.1046/j.1365⁃2133.1999.02815.x. |
[38] | Brzoza Z, Grzeszczak W, Rogala B, et al. PTPN22 polymorphism presumably plays a role in the genetic background of chronic spontaneous autoreactive urticaria[J]. Dermatology, 2012,224(4):340⁃345. doi: 10.1159/000339332. |
[39] | Sadr M, Khalili N, Mohebbi B, et al. Association of PTPN22 single nucleotide polymorphisms with chronic spontaneous urticaria[J]. Allergol Immunopathol (Madr), 2021,49(2):40⁃45. doi: 10.15586/aei.v49i2.53. |
[40] | Zhang L, Qiu L, Wu J, et al. GWAS of Chronic spontaneous urticaria reveals genetic overlap with autoimmune diseases, not atopic diseases[J]. J Invest Dermatol, 2023,143(1):67⁃77.e15. doi: 10.1016/j.jid.2022.07.012. |
[41] | Qu S, Yang L, Liu Z. MicroRNA⁃194 reduces inflammatory response and human dermal microvascular endothelial cells permeability through suppression of TGF⁃β/SMAD pathway by inhibiting THBS1 in chronic idiopathic urticaria[J]. J Cell Biochem, 2020,121(1):111⁃124. doi: 10.1002/jcb.28941. |
[42] | Zhang L, Qi R, Yang Y, et al. Serum miR⁃125a⁃5p and CCL17 upregulated in chronic spontaneous urticaria and correlated with treatment response[J]. Acta Derm Venereol, 2019,99(6):571⁃578. doi: 10.2340/00015555⁃3149. |
[43] | Qi Y, Zhang L, Yang X, et al. Genome⁃wide DNA methylation profile in whole blood of patients with chronic spontaneous urticaria[J]. Front Immunol, 2021,12:681714. doi: 10.3389/fimmu.2021.681714. |
[1] | Chinese Society of Dermatology, China Dermatologist Association. Expert consensus on treat-to-target in chronic spontaneous urticaria (2023) [J]. Chinese Journal of Dermatology, 2023, 56(6): 489-495. |
[2] | Liang Yunsheng, Li Zhanhong, Wu Yibei. Progress in the treatment of chronic spontaneous urticaria: insights from the changes in the understanding of its pathogenesis [J]. Chinese Journal of Dermatology, 2023, 56(6): 552-558. |
[3] | Su Chang, Sui Xiuli, Liu Ruiling, Cao Yiqun, Jiang Hong, Yan Cairong, Wang Huiping, Qi Yuqing. Omalizumab for the treatment of 74 patients with chronic spontaneous urticaria accompanied by other allergic diseases: a clinical analysis [J]. Chinese Journal of Dermatology, 2023, 56(6): 512-517. |
[4] | Wang Xin, Liu Lijuan, Li Linfeng. Clinical features of chronic spontaneous urticaria in China: results from a hospital-based multicenter epidemiological survey [J]. Chinese Journal of Dermatology, 2023, 56(6): 525-530. |
[5] | Li Liqiao, Peng Cong, Chen Xiang, Li Jie. Efficacy of omalizumab in the treatment of chronic urticaria patients with poor response to antihistamines: a single-center retrospective study [J]. Chinese Journal of Dermatology, 2023, 56(6): 504-511. |
[6] | Jiao Qingqing, Zhang Xiaoyan, Ji Jiang. Biological indicators related to disease activity of chronic spontaneous urticaria: an update [J]. Chinese Journal of Dermatology, 2023, 56(6): 559-562. |
[7] | Yu Miao, Song Xiaoting, Liu Bo, Liao Shuanglu, Luan Tingting, Zhao Zuotao. Autologous serum skin test: immunological mechanisms and its associations with clinical features and prognosis of chronic spontaneous urticaria [J]. Chinese Journal of Dermatology, 2023, 56(2): 184-187. |
[8] | . Correlation between food-specific IgG antibodies and phenotypes of chronic spontaneous urticaria [J]. Chinese Journal of Dermatology, 2023, 56(2): 130-135. |
[9] | Zhao Ying, Zhang Xiaoyan, Chen Lu, Su Yuhua, Ding Yujie, Leng Hong, Ji Jiang. Predictive factors for the efficacy of omalizumab in the treatment of refractory chronic spontaneous urticaria [J]. Chinese Journal of Dermatology, 2023, 56(1): 22-28. |
[10] | Liu Jin, Shen Zhengyu. Epigenetic regulation in psoriasis [J]. Chinese Journal of Dermatology, 2022, 55(9): 825-829. |
[11] | Committee on Autoimmune Diseases, China Dermatologist Association. Cyclosporine in the treatment of immune-related skin diseases: an expert proposal [J]. Chinese Journal of Dermatology, 2022, 55(6): 471-479. |
[12] | Shan Ying, Zuo Yagang. Correlation between autoimmune bullous diseases and psoriasis [J]. Chinese Journal of Dermatology, 2022, 55(5): 452-455. |
[13] | Zhao Wenling, Yang Yuyan, Li Li, Jin Hongzhong. Bullous pemphigoid and its immune-mediated comorbidities [J]. Chinese Journal of Dermatology, 2022, 55(2): 177-181. |
[14] | Chinese Society of Dermatology, China Dermatologist Association. Consensus on the diagnosis and treatment of autoimmune subepidermal bullous diseases (2022) [J]. Chinese Journal of Dermatology, 2022, 55(1): 1-11. |
[15] | Autoimmune Disease Group, China Dermatologist Association. Chinese expert consensus on cyclophosphamide for the treatment of autoimmune dermatoses [J]. Chinese Journal of Dermatology, 2021, 54(9): 765-770. |
|